XML 51 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Share based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Fair Value of Options
The fair value of the stock options granted is estimated on the date of grant using a Black-Scholes option pricing model with the following weighted-average assumptions:
Years Ended December 31,
202020192018
Expected stock price volatility75.1 %74.1 %78.6 %
Risk free interest rate1.6 %2.4 %2.4 %
Expected life of options (years) 5.675.685.62
Expected annual dividend per share$0.00 $0.00 $0.00 
Schedule of Stock Options Activity
A summary of the Company's stock options for the year ended December 31, 2020 were as follows:
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Years
Aggregate
Intrinsic
Value
(in thousands)(in millions)
Options outstanding, December 31, 201715,181 $7.48 
Granted2,348 $14.96 
Exercised(1,398)$6.54 
Forfeited(313)$9.55 
Expired(8)$10.76 
Options outstanding, December 31, 201815,810 $8.63 
Granted4,091 $10.29 
Exercised(1,967)$5.83 
Forfeited(879)$11.07 
Expired(331)$13.38 
Options outstanding, December 31, 201916,724 $9.15 
Granted4,362 $9.98 
Exercised(5,243)$8.11 
Forfeited(1,376)$10.42 
Expired(435)$13.33 
Options outstanding, December 31, 202014,032 $9.54 6.5$190.1 
Vested and unvested expected to vest, December 31, 202013,267 $9.49 6.4$180.5 
Exercisable at December 31, 20208,130 $8.86 5.1$115.7 
Schedule of Non-Vested RSU Activity under the Plan A summary of non-vested RSU activity under the Plan for the year ended December 31, 2020 is as follows:
 
Number of
Shares
Weighted
Average Grant
Date Fair
Value
Weighted
Average
Remaining
Years
Aggregate
Intrinsic
Value
 
(in thousands)
(in millions)
Non-vested units as of December 31, 20172,575 $5.85 
Granted1,812 $16.11 
Vested(530)$6.01 
Forfeited(145)$9.65 
Non-vested units as of December 31, 20183,712 $10.59 
Granted3,526 $10.92 
Vested(921)$8.49 
Forfeited(525)$10.52 
Non-vested units as of December 31, 20195,792 $11.18 
Granted4,692 $11.29 
Vested(2,164)$10.70 
Forfeited(1,240)$11.14 
Non-vested units as of December 31, 20207,080 $11.35 2.3$158.0 
Schedule of Equity Compensation Expenses
The following table summarizes information related to compensation expense recognized in the Consolidated Statements of Operations related to the equity awards:
Years Ended December 31,
(in thousands)202020192018
Equity compensation expense recognized in:
Research and development expense$20,817 $17,575 $11,740 
Selling, general, and administrative expense28,334 26,855 17,520 
Total equity compensation expense$49,151 $44,430 $29,260